Gefitinib in Combination with Oxaliplatin and 5-Fluorouracil in Irinotecan-Refractory Patients with Colorectal Cancer: A Phase I Study of the Arbeits gemeinschaft Internistische Onkologie (AIO)

Publisher： Karger

E-ISSN： 2296-5262|31|5|237-241

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.5, 2008-04, pp. : 237-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gefitinib in Combination with 5-Fluorouracil (5-FU)/Folinic Acid and Irinotecan in Patients with 5-FU/Oxaliplatin- Refractory Colorectal Cancer: A Phase I/II Study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO)

By  

Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. : 563-567

Karger

Access to resources Recommend Favorite

Gefitinib in Combination with Capecitabine as Second-Line Therapy in Patients with Advanced Colorectal Cancer (aCRC): A Phase I/II Study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

By  

Oncology Research and Treatment, Vol. 33, Iss. 3, 2010-02 ,pp. : 89-93

Karger

Access to resources Recommend Favorite

Multicenter Phase I Study of Irinotecan plus Raltitrexed in Patients with 5-Fluorouracil-Refractory Advanced Colorectal Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 42-47

Karger

Access to resources Recommend Favorite

A Phase I Study of Infusional 5-Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan in Japanese Patients with Advanced Colorectal Cancer Who Harbor UGT1A1*1/*1,*1/*6 or *1/*28

By  

Oncology, Vol. 82, Iss. 4, 2012-04 ,pp. : 242-248

Karger

Access to resources Recommend Favorite

The Role of 5-Fluorouracil (5-FU) Reintroduction with Irinotecan or Oxaliplatin in Truly 5-FU-Refractory Advanced Colorectal Cancer Patients

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 212-216

Karger

Access to resources Recommend Favorite